Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.
about
The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?Type II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: mendelian randomization studyNoninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profilingA-002 (Varespladib), a phospholipase A2 inhibitor, reduces atherosclerosis in guinea pigs.Quick identification of acute chest pain patients study (QICS).Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2)A lipid peroxidation product 9-oxononanoic acid induces phospholipase A2 activity and thromboxane A2 production in human blood.Functional analysis of two PLA2G2A variants associated with secretory phospholipase A2-IIA levels.Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levelsAssociation between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: a clinical trialThe 763C>G Polymorphism of The Secretory PLA2IIa Gene Is Associated with Endometriosis in Iranian WomenPrognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease.Periodontal microbiota and phospholipases: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).Pathogen burden, cytomegalovirus infection and inflammatory markers in the risk of premature coronary artery disease in individuals of Indian origin.Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate.Circulating n-3 fatty acids and trans-fatty acids, PLA2G2A gene variation and sudden cardiac arrest.Secretory Phospholipase A2 Is Associated with the Odds of Acute Coronary Syndromes through Elevation of Serum Amyloid-A Protein.Molecular and functional characterization of polymorphisms in the secreted phospholipase A2 group X gene: relevance to coronary artery diseaseIntegrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patients.Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study.Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome.Secreted phospholipase A2, lipoprotein hydrolysis, and atherosclerosis: integration with lipidomicsFrom circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population.Update in therapeutic approaches to plaque stabilization.Biomarkers of plaque instability.Mendelian randomisation applied to drug development in cardiovascular disease: a review.The Notch pathway attenuates interleukin 1β (IL1β)-mediated induction of adenylyl cyclase 8 (AC8) expression during vascular smooth muscle cell (VSMC) trans-differentiation.Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain.Secretory phospholipase A2 increases SR-BI-mediated selective uptake from HDL but not biliary cholesterol secretion.Lp-PLA2 et sPLA2Mendelian Randomization Studies Promise to Shorten the Journey to FDA Approval
P2860
Q24317652-83180F78-145C-4D15-ADD8-B167DB085A99Q28479244-DFA7CC63-0704-4BA0-A9C9-CAE3A1F36BAAQ33355010-1D8FCD1D-C35A-4437-A763-E319B6ABB546Q33410007-D29834D4-0AA3-4E4D-A32B-641268EF469BQ33467558-4F7DDEE0-7F2D-4555-A043-504C7C7050F5Q33741235-3A67C526-FBC4-4CF7-914F-F5317CACB6E2Q34346520-045663A5-D0B1-4989-986A-091F13717E12Q34373883-5986EEF9-8336-4A0A-B132-AAEF8D1E37C5Q34418471-BC9ED231-F376-436C-8229-523C8B4D45D3Q35125145-8E6E3BBF-E660-40F7-8C29-D20E543E8546Q35166396-F52E4367-709D-4A7B-9A93-399BCD3E1F91Q35627513-CAF0DC1C-FA2A-48DE-97D1-37740D9CE124Q35748267-DD791720-CE70-48A3-9E54-CC3314CDD86EQ36091407-843E779D-D3EA-49D4-A7CC-4293C6F88F70Q36459773-CC7B4DF8-288B-420B-B701-98655627A23FQ36686221-C0972419-4BF6-4589-A61A-BB126F699292Q36975612-82C0611E-F90B-43A3-A480-F6815E0CF97FQ37238669-1E46198A-C4F6-4F60-BCE0-4AD712229E95Q37277958-FB2C8CAF-BDAB-4EFA-93BF-2EE45D663E25Q37303915-F6A54E32-224B-4C65-8071-DBFD0A6ED1B2Q37492990-3A688FF7-29A8-4447-860D-0F33677F0473Q37858911-A5BBD8DB-FFE4-4ABC-80C0-CED61DA22451Q37881966-B3F017D5-730A-46D7-9EC0-60861B4BB00AQ38178537-256014D0-2FAD-4985-A628-8ED6E62FC561Q38261198-393F19E4-F061-4E2C-B1FF-3443B864B8E1Q38290764-415F7C87-D543-4EE7-8155-7A68371B5290Q42255131-6796E0A7-DE2D-44FF-83BC-336A4B96161FQ44257097-00B1D75B-CC75-4095-A3D6-15DF9782B66DQ46882730-B561F28C-FDBD-4DAB-91C8-882073B2C69CQ58148425-7C34AFE2-FFA1-47AB-B2FF-68BC14561347Q59129593-62DD01C0-3501-4099-A0DE-FB32C6CEBC91
P2860
Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Circulating secretory phosphol ...... vere acute coronary syndromes.
@ast
Circulating secretory phosphol ...... vere acute coronary syndromes.
@en
Circulating secretory phosphol ...... vere acute coronary syndromes.
@nl
type
label
Circulating secretory phosphol ...... vere acute coronary syndromes.
@ast
Circulating secretory phosphol ...... vere acute coronary syndromes.
@en
Circulating secretory phosphol ...... vere acute coronary syndromes.
@nl
prefLabel
Circulating secretory phosphol ...... vere acute coronary syndromes.
@ast
Circulating secretory phosphol ...... vere acute coronary syndromes.
@en
Circulating secretory phosphol ...... vere acute coronary syndromes.
@nl
P2093
P50
P1476
Circulating secretory phosphol ...... vere acute coronary syndromes.
@en
P2093
Anne Dauphin
Bernard Asselain
Bénédicte Hugel
Carla Sibella Arguelles
Jean-Marie Freyssinet
Jean-Philippe Collet
Joëlle Benessiano
Kathryn F Carruthers
Keith A Fox
Marie-Laure Tanguy
P304
P356
10.1016/J.JACC.2005.06.056
P407
P577
2005-10-01T00:00:00Z